One and done: Reasons principal investigators conduct only one FDA-regulated drug trial

Concerns have been raised over the high turnover rate for clinical investigators. Using the U.S. Food and Drug Administration's (FDA) Bioresearch Monitoring Information System database, we conducted an online survey to identify factors that affect principal investigators' (PIs) decisions t...

Descripción completa

Detalles Bibliográficos
Autores principales: Corneli, Amy, Pierre, Christine, Hinkley, Terri, Lin, Li, Fordyce, Christopher B., Hamre, Gerrit, Roe, Matthew T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5936741/
https://www.ncbi.nlm.nih.gov/pubmed/29740635
http://dx.doi.org/10.1016/j.conctc.2017.02.009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5936741/
https://www.ncbi.nlm.nih.gov/pubmed/29740635
http://dx.doi.org/10.1016/j.conctc.2017.02.009

Ejemplares similares